23andMe laying off 14% of employees amid slump in DNA spit kit sales
by Erin Brodwin
Jan 23, 2020
1 minute
In the latest sign of a slump in consumer genetic testing, 23andMe is laying off 14% of its workforce amid falling sales of its DNA spit kits. The cut of about 100 jobs, which could be the company’s largest downsize yet,.
You’re reading a preview, subscribe to read more.
Start your free 30 days